Literature DB >> 22620282

Wound debridement potential of glycosidases of the wound-healing maggot, Lucilia sericata.

G Telford1, A P Brown, A Rich, J S C English, D I Pritchard.   

Abstract

The wound-healing maggot, Lucilia sericata Meigen (Diptera: Calliphoridae), degrades extracellular matrix components by releasing enzymes. The purpose of this study was to investigate the glycosylation profiles of wound slough/eschar from chronic venous leg ulcers and the complementary presence of glycosidase activities in first-instar excretions/secretions (ES1) and to define their specificities. The predominant carbohydrate moieties present in wound slough/eschar were determined by probing one-dimensional Western blots with conjugated lectins of known specificities. The presence of specific glycosidase activities in ES1 was determined using chromogenic and fluorogenic substrates. The removal of carbohydrate moieties from slough/eschar proteins by glycosidases in ES1 was determined by two-dimensional electrophoresis and Emerald 300 glycoprotein staining. α-D-glucosyl, α-D-mannosyl and N-acetylglucosamine residues were detected on slough/eschar-derived proteins. Furthermore, it was demonstrated that the treatment of slough/eschar with ES1 significantly reduced uptake of the carbohydrate-specific stain. Subsequently, α-D-glucosidase, α-D-mannosidase and N-acetylglucosaminidase activities were identified in ES1. Specific chromogenic and fluorogenic substrates and gel filtration chromatography showed that these activities result from distinct enzymes. These activities were mirrored in the removal of α-D-glucosyl, α-D-mannosyl and N-acetylglucosamine residues from proteins of slough/eschar from maggot-treated wounds. These data suggest that maggot glycosidases remove sugars from slough/eschar proteins. This may contribute to debridement, which is ultimately accomplished by a suite of biochemically distinct enzymes present in ES1.
© 2012 The Authors. Medical and Veterinary Entomology © 2012 The Royal Entomological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22620282     DOI: 10.1111/j.1365-2915.2011.01000.x

Source DB:  PubMed          Journal:  Med Vet Entomol        ISSN: 0269-283X            Impact factor:   2.739


  7 in total

1.  What is the optimal treatment time for larval therapy? A study on incubation time and tissue debridement by bagged maggots of the greenbottle fly, Lucilia sericata.

Authors:  Michael R Wilson; Yamni Nigam; John Knight; David I Pritchard
Journal:  Int Wound J       Date:  2018-10-31       Impact factor: 3.315

2.  Degradation of MSCRAMM target macromolecules in VLU slough by Lucilia sericata chymotrypsin 1 (ISP) persists in the presence of tissue gelatinase activity.

Authors:  David I Pritchard; Alan P Brown
Journal:  Int Wound J       Date:  2013-07-09       Impact factor: 3.315

3.  Evaluation of larval density Cochliomyia macellaria F. (Diptera: Calliphoridae) for therapeutic use in the recovery of tegumentar injuries.

Authors:  Mariana Prado Nassu; Patricia Jacqueline Thyssen
Journal:  Parasitol Res       Date:  2015-05-30       Impact factor: 2.289

4.  Characterisation of the small RNAs in the biomedically important green-bottle blowfly Lucilia sericata.

Authors:  Cherie Blenkiron; Peter Tsai; Lisa A Brown; Vernon Tintinger; Kathryn J Askelund; John A Windsor; Anthony R Phillips
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

Review 5.  Wound debridement products and techniques: clinical examples and literature review.

Authors:  Marcela Nowak; Dorota Mehrholz; Wioletta Barańska-Rybak; Roman J Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2022-07-14       Impact factor: 1.664

6.  A novel serine protease secreted by medicinal maggots enhances plasminogen activator-induced fibrinolysis.

Authors:  Mariena J A van der Plas; Anders S Andersen; Sheresma Nazir; Nico H van Tilburg; Peter R Oestergaard; Karen A Krogfelt; Jaap T van Dissel; Paul J Hensbergen; Rogier M Bertina; Peter H Nibbering
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

Review 7.  Recent advances in developing insect natural products as potential modern day medicines.

Authors:  Norman Ratcliffe; Patricia Azambuja; Cicero Brasileiro Mello
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-06       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.